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ABSTRACT The interaction of the a5b1 integrin and its ligand, ﬁbronectin (FN), plays a crucial role in the adhesion of cells to
the extracellular matrix. An important intrinsic property of the a5b1/FN interaction is the dynamic response of the complex to
a pulling force. We have carried out atomic force microscopy measurements of the interaction between a5b1 and a ﬁbronectin
fragment derived from the seventh through tenth type III repeats of FN (i.e., FN7-10) containing both the arg-gly-asp (RGD)
sequence and the synergy site. Direct force measurements obtained from an experimental system consisting of an a5b1
expressing K562 cell attached to the atomic force microscopy cantilever and FN7-10 adsorbed on a substrate were used to
determine the dynamic response of the a5b1/FN7-10 complex to a pulling force. The experiments were carried out over a three-
orders-of-magnitude change in loading rate and under conditions that allowed for detection of individual a5b1/FN7-10
interactions. The dynamic rupture force of the a5b1/FN7-10 complex revealed two regimes of loading: a fast loading regime
([10,000 pN/s) and a slow loading regime (\10,000 pN/s) that characterize the inner and outer activation barriers of the
complex, respectively. Activation by TS2/16 antibody increased both the frequency of adhesion and elevated the rupture force
of the a5b1/wild type FN7-10 complex to higher values in the slow loading regime. In experiments carried out with a FN7-10
RGD deleted mutant, the force measurements revealed that both inner and outer activation barriers were suppressed by the
mutation. Mutations to the synergy site of FN, however, suppressed only the outer barrier activation of the complex. For both the
RGD and synergy deletions, the frequency of adhesion was less than that of the wild type FN7-10, but was increased by integrin
activation. The rupture force of these mutants was only slightly less than that of the wild type, and was not increased by
activation. These results suggest that integrin activation involved a cooperative interaction with both the RGD and synergy sites.
INTRODUCTION
The interaction between a5b1 integrin and fibronectin (FN)
plays an important role in cell differentiation, proliferation
(Garcia et al., 1999; Molla and Block 2000) and migration
(Pierini et al., 2000) by serving as a bridge between the cell
and the extracellular matrix that mediates bidirectional
signaling events through inside-out and outside-in pathways
(Yamada and Miyamoto 1995; Fernandez et al., 1998).
Altered expression of the a5b1 integrin and fibronectin has
been correlated with both physiological and pathological
processes including neural development, wound healing,
tumor metastasis, and atherosclerosis (Barillari et al., 2001;
Greiling and Clark, 1997; Taverna and Hynes, 2001; Goh
et al., 1997). In animal models, mouse embryos lacking
fibronectin showed defects in the mesoderm, the neural tube,
and in vascular development, and died by embryonic day 9
(George et al., 1993).
The integrin a5b1 is one of 24 known members of the
integrin family of adhesion molecules, formed by the
noncovalent assembly of an a-subunit (i.e., a5) and a
b-subunit (i.e., b1) (Hynes, 1992). Both subunits consist
of large extracellular domains of more than 940 (a5) and
630 residues (b1), a transmembrane domain, and a short
cytoplasmic domain (Coe et al., 2001; Mould et al., 1997).
The current model for the structural organization of a5b1 is
largely based on the crystal structure of the aVb3 integrin
(Xiong et al., 2001). The ligand-binding ‘‘head’’ region of
the a5b1 is formed by the N-terminal seven bladed
b-propeller domain of a5 and the I-like domain of b1
(Mould et al., 2000; Springer 1997). Structural elements in
the ‘‘head’’ region implicated in FN binding include the
metal ion dependent adhesion site (MIDAS) of b1, and the
two to four repeats of the b-propeller of a5 (Coe et al., 2001;
Xiong et al., 2001; 2002).
Fibronectin, a major element of the extracellular matrix in
many tissues, is a dimeric glycoprotein, and serves as a ligand
for a5b1. Each subunit is composed of multiple homologous
domains termed FNI, FNII, and FNIII. The arg-gly-asp
(RGD) sequence in FNIII domain 10 (FN10) is the crucial
attachment site for FN receptors, including the integrin a5b1
(Pierschbacher and Ruoslahti, 1984; Yamada and Kennedy,
1984). A synergy site that is important for binding a5b1 is
located in FN9 (Aota et al., 1994; Kimizuka et al., 1991;
Obara et al., 1988, Danen et al., 1995). The sequence PHSRN
was earlier reported to be important for the synergy effect
(Bowditch et al., 1994, Aota et al., 1994) but more recently
the synergy site has been identified as a more extended
surface of FN9 (Redick et al., 2000; Kauf et al., 2001).
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In recent years extensive studies have been focused on the
molecular basis of integrin–ligand binding. The binding
pocket of the a5b1/fibronectin interaction appears to be more
complex and involves both a- and b-subunits of the integrin
and FN9 and FN10 of fibronectin as determined by antibody
mapping, mutagenesis, and structural studies. Crystallo-
graphic analysis of the aVb3 integrin complexed to a cyclic
RGD peptide suggests that the RGD loop in FN10 is rec-
ognized by both a5 and b1 subunits (Xiong et al., 2002).
The aspartate residue coordinates with the metal ion in the
MIDAS of the bA domain and the arginine and glycine
residues make contact with the b-propeller of the a5 subunit
(Xiong et al., 2002). The synergy site in FN9 comprises half
a dozen surface amino acids on the side of the domain facing
the direction of the RGD (Redick et al., 2000, Kauf et al.,
2001) and is recognized primarily by the third and fourth
repeats in the b-propeller of the a5 subunit (Burrows et al.,
1999; Mould et al., 1997; Mould et al., 1998).
Recent models predict that the a5b1 integrin can exist in
multiple conformational states (inactivated, intermediate ac-
tivated, and fully activated) that have different affinities for
FN (Garcia et al., 1998b). The a5b1 integrin is activated by
inside-out signaling that appears to act on the cytoplasmic
tails, which releases the constraint between the two subunits
and subsequently exposes a high affinity ‘‘open’’ conforma-
tion for ligand binding (Takagi et al., 2001). a5b1 can also be
activated by nonphysiological stimuli such as activating
monoclonal antibodies (e.g., TS2/16 and AG89; Arroyo
et al., 1993; Tsuchida et al., 1998) and high concentrations of
extracellular Mg2þ or Mn2þ (Mould et al., 1995). Structural
analysis of the aVb3 integrin has lent support to the idea that
a5b1 activation may involve conformational change in the
bA domain and a reorientation of the extracellular domains
of the a- and b-subunits (Xiong et al., 2002).
Cell–matrix interactions usually occur in the context of
a complex process where either an external or internal force
acts on the cell. For example, when cells migrate, the traction
force generated inside the cell is applied to the integrin/FN
linkages. It is, therefore, important to understand how
a pulling force affects the dynamics of the integrin–ligand
complex.
A number of advanced techniques have been developed to
measure the rupture force of molecular adhesion. Commonly
used techniques employed in single molecule force measure-
ments include the biomembrane force probe (Evans et al.,
1995), the atomic force microscopy (AFM) (Moy et al.,
1994), optical tweezers (Litvinov et al., 2002; Thoumine
et al., 2000; Thoumine and Meister, 2000), and the parallel-
plate flow chamber (Chen and Springer 2001). The dynamics
of selectin-mediated adhesion was characterized by bio-
membrane force probe and AFMmeasurements (Evans et al.,
2001; Fritz et al., 1998), and in the parallel-plate flow
chamber (Chen and Springer 2001). The AFM technique was
also used to measure the adhesion force between osteoblast
and several RGD-containing ligands (Lehenkari and Horton
1999). In a recent study closely related to ours, Litvinov et al.
(2002) used laser tweezers to measure the rupture force of
aIIbb3 integrin to fibrinogen, with the integrin both on living
platelets and as purified protein (Litvinov et al., 2002).
In this report, we present direct force measurements,
acquired by AFM, of the interaction between the integrin
a5b1 and fibronectin. In these experiments, we used the
K562 cell line, which expresses the a5b1 integrin, but no
other FN receptors (Hemler et al., 1987). Our measurements
were carried out using the fibronectin fragment, FN7-10,
which consists of FN type III repeats 7–10, rather than whole
plasma fibronectin to avoid misinterpretation of measure-
ments acquired from a system that has multiple binding sites
(Hocking et al., 1998). The a5b1 integrins of K562 cells
are constitutively inactive, but can be activated by various
monoclonal antibodies against b1 (e.g., TS2/16). The ac-
quired data were analyzed in the framework of the dynamic
force model of Evans and Ritchie (1997). Studies were also
carried out with FN fragments that contain either a deletion
of RGD sequence or mutations of the synergy site to identify
the contributions of these sites to the interactions of the a5b1/
FN complex.
METHODS
Cells and reagents
The a5b1-expressing K562 (ATCC, CCL-243) cell lines was maintained in
continuous culture in RPMI 1640 medium supplemented with 10% heat-
inactivated fetal calf serum (Irvine Scientific, Santa Ana, CA), penicillin (50
U/ml, Gibco BRL, Grand Island, NY) and streptomycin (50 mg/ml, GIBCO
BRL). The K562 cells were expanded on a 3-day cycle.
The TS2/16 monoclonal antibody, which activates b1 integrins, was
derived from supernatants of hybridoma cells (ATCC, HB243) maintained
in culture. The K562 cells were activated by adding 1/10 volume (v/v) of
TS2/16 culture supernatant for 10 min at room temperature. The anti-b1
integrin monoclonal antibody, P5D2, which inhibits the binding of b1
integrins to FN, was a generous gift from Dr. J. Li (Dept. of Dermatology,
University of Miami) (Caixia et al., 1991). JBS5 is a mouse IgG against a5
integrins and was purchased from Serotec (Raleigh, NC) (Wayner et al.,
1993). Polyclonal mouse IgG was purchased from Sigma (St. Louis, MO).
A plasmid containing FN7-10 in the pET11b vector was previously
described (Aukhil et al., 1993; Leahy et al., 1996). A mutant deleting the
RGD (FN7-10(DRGDS)), and a triple mutant that inactivates the synergy
site (FN7-10(R1374A/P1376A/R1379A), referred to as FN7-10(Dsyn)),
were described in Redick et al. (2000). Proteins were expressed in BL21
cells and purified by (NH4)2SO4 precipitation followed by chromatography
on a mono Q and crystallization in low pH sodium formate (Redick et al.,
2000). Human plasma fibronectin (pFN) was purchased from Sigma and
used without further purification.
Attachment of cell to AFM cantilever
K562 cells were attached to the AFM cantilever by concanavalin A (Con A)-
mediated linkages. The cantilevers were soaked in acetone for 5 min, UV
irradiated for 30 min, and incubated in biotinamidocaproyl-labeled bovine
serum albumin (biotin-BSA, 0.5 mg/ml; Sigma) overnight at 378C. The
cantilevers were then rinsed three times with phosphate buffer and incubated
in 0.5 mg/ml streptavidin (Pierce; Rockford, IL) for 10 min at room
temperature. After the removal of unbound streptavidin, the cantilevers were
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incubated in 0.5 mg/ml biotinylated Con A (Sigma) and then rinsed. To
attach the cell to the cantilever, the tip of the Con A-functionalized cantilever
was positioned above the cell and lowered onto the cell for ;1 s. The
attached cell was positioned behind the tip of the cantilever as shown in Fig.
1. To obtain an estimate of the strength of the cell–cantilever linkage, we
allowed the attached cell to interact with a petri dish coated with Con A.
Upon retraction of the cantilever, separation always (N [ 20) occurred
between the cell and the Con A-coated petri dish. In these measurements, the
average force needed to induce separation was[2 nN, much larger than the
forces found for an individual a5b1/FN bond. This observation is important
inasmuch as it ensures that the cell remained bound to the cantilever during
the single molecule a5b1/FN force measurements.
Immobilized protein
Whole human plasma fibronectin, FN7-10, or FN7-10 with deleted RGD or
synergy site mutants (100 mg/ml in 0.1M NaHCO3) were adsorbed
overnight at 48C on 35-mm tissue culture dishes. Unbound FNs were
removed and the dish was incubated with 1% bovine albumin for 1 h at 378C
to block the exposed surface of the tissue culture dish.
AFM force measurements
The AFM force measurements were performed on an apparatus designed to
be operated in the force spectroscopy mode (Heinz and Hoh, 1999). A K562
cell was attached to the end of the AFM cantilever as described above.
A piezoelectric translator was used to lower the cantilever/cell onto the FN-
coated dish. Contact between the attached K562 cell and the sample was
indicated by deflection of the cantilever, which was measured by reflecting
a laser beam off the cantilever into a position sensitive two-segment
photodiode detector.
Measurements of unitary a5b1/FN rupture forces were obtained under
conditions that minimized contact between the K562 cell and the FN-coated
dish. An adhesion frequency of\30% in the force measurements ensured
that there is a [83% probability that the adhesion event is mediated by
a single a5b1/FN bond (Merkel et al., 1999; Tees et al., 2001). We were able
to acquire measurements with loading rates between 10 and 50,000 pN/s by
adjusting the retraction speed of the cantilever (1–15mm/s) and by variations
in the local elasticity of the cell (0.01–5.0 mN/m) that allowed for the system
spring constant (the cell–cantilever combination) to vary between 0.01 and
3.33 mN/m. To satisfy the condition of constant loading rate required for our
analysis, measurements were selected for our analysis only if there was
a sustained linear increase in force with respect to time before bond
dissociation. At fast cantilever retraction speeds ([1 mm/s), the hydrody-
namic drag on the cantilever resulted in smaller forces recorded than were
actually applied to rupture the complex. To correct for the hydrodynamic
force exerted on the cantilever, we determined the damping coefficient of the
cantilever j (;2 pN-s/mm) in the culture medium by measuring the
deflection of cantilever at different retraction speeds. The rupture force
plotted in Figs. 4–8 is the sum of the measured force and the hydrodynamic
force. All AFM force measurements were carried out at 258C with fresh
culture medium supplemented with 10 mM HEPES buffer.
The AFM cantilevers were purchased from TMMicroscopes (Sunnyvale,
CA). The largest triangular cantilever (320 mm long and 22 mm wide) from
a set of five on the cantilever chip was used in our measurements. These
cantilevers were calibrated by analysis of their thermally induced fluctuation
to determine their spring constant (Hutter and Bechhoefer, 1993). The
experimentally determined spring constants were consistent with the
nominal value of 10 mN/m given by the manufacturer.
RESULTS
Measurements of a5b1/FN interactions by AFM
Direct force measurements by AFM were employed to
characterize the adhesive interaction between immobilized
FN and a5b1 integrin expressed on the surface of the human
chronic myelogenous leukemia cell line, K562. The cell
adhesion studies were carried out with a K562 cell coupled to
the AFM cantilever and FN adsorbed to a tissue culture dish
(Fig. 1). In these measurements, the K562 cell was lowered
onto the dish until contact was made. The interaction
between the cell and the dish was regulated by the applied
force of 100–500 pN exerted by the cantilever. After a given
contact duration, the K562 cell was withdrawn from the dish
at a separation rate of 5 mm/s while the force versus piezo
displacement trace of the process was recorded (Fig. 2 A).
The adhesive interactions between the cell and protein
coating on the dish were detected as downward deflections
of the cantilever. We and others have found that this
experimental design allows investigators to study the
dynamics of cell adhesion involving many adhesion
molecules, as well as the properties of individual molecular
complexes (Benoit et al., 2000; Zhang et al., 2002).
Fig. 2A presents measurements acquired under conditions
where cell adhesion was mediated by multiple a5b1/FN7-10
complexes. These complexes did not necessarily rupture
simultaneously during detachment as revealed by the
‘‘sawtooth’’ profile in the AFM traces. Each of the force
jumps as indicated by the arrows in Fig. 2 A is interpreted to
correspond to the breakage of one or more a5b1/FN7-10
complexes. It is unlikely that these force jumps corresponded
to the breakage of other molecular linkages and/or the
unfolding of proteins on the basis of single molecule
measurement analysis as discussed below. Adhesion be-
tween the K562 cell and FN7-10 increased after the addition
of TS2/16, an activating monoclonal antibody against b1
integrins (Arroyo et al., 1993). Activation of a5b1 by TS2/16
was dose-dependent. 10% culture supernatant of TS2/16
(;1 mg/ml antibody in final concentration) was sufficient to
fully activate a5b1. Higher concentrations (up to 20 mg/ml)
FIGURE 1 Micrograph of a K562 cell attached to the end of an AFM
cantilever. The bar is 20 mm.
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of TS2/16 did not augment adhesion relative to the adhesion
level observed with 1 mg/ml TS2/16 (data not shown). As
shown in the middle trace of Fig. 2 A, the number of force
jumps increased, reflecting the increase in the number of
a5b1/FN7-10 complexes formed after TS2/16 treatment. The
addition of P5D2, a function-blocking anti-b1 monoclonal
antibody significantly lowered the adhesion (Fig. 2 A,
bottom trace), whereas antimouse IgG (50 mg/ml) had no
effect on cell adhesion.
Fig. 2 B summarizes the results from a series of force
measurements using the detachment energy to quantify cell
adhesion under different experimental conditions. The
detachment energy was obtained by integrating the pulling
force over displacement of the cell until the last of the a5b1/
FN complexes ruptured. It should be noted that this
detachment energy is the work done to break the a5b1
bonds as well as the work done to deform the cell during the
detachment process. The detachment energy depends on the
number of a5b1/FN complexes formed when the cell is
pressed against the FN-coated substrate, and hence on the
applied force and the duration of cell–substrate contact. To
permit direct comparison of the detachment energy, the
values plotted in Fig. 2 B were obtained from measurements
carried out at the same compression force (150 pN), contact
duration (1 s), and retraction speed (5 mm/s). As shown,
adhesion was augmented fivefold by integrin activation with
the TS2/16 antibody. Adhesions of both untreated and
activated cells to FN7-10 were inhibited by the anti-b1
antibody, P5D2 (20 mg/ml), and by 5 mM EDTA, but not by
nonspecific polyclonal murine IgG (50 mg/ml). Moreover,
both untreated and activated cells did not adhere to
immobilized BSA. These experiments demonstrated that
the adhesion between K562 and an FN-coated petri dish was
largely due to the a5b1/FN interaction.
AFM measurements of individual
a5b1/FN interactions
To assess the bond strength of an individual a5b1/FN7-10
interaction, contact between the cell and the dish was
minimized by reducing both contact duration (\50 ms) and
compression force (100 pN). Examples of unfiltered force
measurements acquired under these conditions are shown in
Fig. 3 A. Under these conditions ;30% of measurements
resulted in adhesion (i.e., a 30% frequency of adhesion).
Traces that registered a sharp transition of more than 30 pN
were counted as an adhesion event. Forces of less than 30 pN
were excluded inasmuch as the observed fluctuations of the
free cantilever were frequently 20 pN. The rupture force of
the a5b1/FN7-10 complex was derived from the magnitude
of the force transition after correction for hydrodynamic
drag. It should be noted that the majority of the measure-
ments acquired under these conditions registered a single
transition in force. This transition stemmed from the forced
unbinding of a single a5b1/FN7-10 complex. Moreover,
such observations also revealed that the dissociation of the
a5b1/FN7-10 complex does not involve the initial unfolding
of the proteins as observed in the forced unfolding of FN
domains (Oberhauser et al., 1998).
To assess the contributions of the RGD loop and of the
synergy site residues of FN to the binding force of the a5b1/
FN interaction, we have obtained measurements of the mean
rupture forces of untreated and activated a5b1 complexed to
FN7-10, FN7-10(Dsyn), and FN7-10(DRGD). The force
values presented in Fig. 3 B were from measurements
acquired at loading rates of 1800–2000 pN/s. Under these
conditions, the mean rupture force of the a5b1/FN7-10
complex was elevated from 69 pN 6 1.5 (mean6 SE) to 93
pN 6 1.5 after integrin activation by the TS2/16 mAb.
FIGURE 2 AFM force measurements of a5b1-mediated cell adhesion.
(A) A series of AFM force-displacement retract traces of the interaction
between an unactivated K562 cell and FN7-10 (top record, approach and
retract traces), after the K562 cell was activated by 10% TS2/16 (middle
record, retract trace only) and in the presence of antibodies (P5D2, 20 mg/
ml) against the b-subunit of a5b1 (bottom record, retract trace only). The
arrows point to the positions in the traces where the a5b1/FN7-10 complex
ruptured. The shaded area in the middle trace is the detachment energy. (B)
Detachment energies of a5b1-mediated cell adhesion for different cell states.
Higher detachment energies are due to both a larger number of adhesions
and larger forces of detachment. The error bar is the standard deviation.
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However, there was no enhancement in the bond strength of
either a5b1/FN7-10(Dsyn) or a5b1/FN7-10(DRGD) com-
plexes after antibody activation. The force measurements
also revealed a slightly lower rupture force for both a5b1/
FN7-10(Dsyn) and a5b1/FN7-10(DRGD) complexes rela-
tive to the wild type complex.
The specificity of these measurements was verified by
a significant reduction in the frequency of adhesion after the
addition of the function-blocking anti-a5 antibody, JBS5
(Fig. 3 C). The frequency of adhesion did not change when
polyclonal murine IgG (50 mg/ml) was added (data not
shown). Interestingly, the frequency of adhesion for a5b1/
FN7-10 interactions is only doubled when the integrin is
activated. However, it should be emphasized that the
adhesion frequency is dependent on the association rate of
the a5b1/FN interaction and the lateral diffusion of a5b1.
Inasmuch as the force measurements were carried out with
surface contact time of less than 50 ms, there was insufficient
time for a complete lateral redistribution of membrane
proteins. Hence, under these conditions, differences in the
frequency of adhesion of the different a5b1/FN pairs
reflected differences in the association rate (kon) of the
different pairs. Our observation that the number of adhesions
is only doubled for FN7-10 when the integrin is activated
revealed that the kon of activated a5b1 is slightly faster than
the kon of the low affinity a5b1. This suggests that the en-
hanced cell adhesion stemmed primarily from changes in
the dissociation rate of the complex.
Fig. 4, A–D present histograms of the rupture force of the
a5b1/FN7-10 complex. A shift in the force histogram toward
higher forces was observed with increasing force loading
rates for both untreated (compare Fig. 4, A and B) and TS2/
16 activated (compare Fig. 4, C and D) K562 cells. There
was also a shift toward higher forces (compare Fig. 4, A and
C) upon cell activation at a slow loading rate (230–240 pN/
s), but not at the fast loading rate of 13,000–13,500 pN/s
(compare Fig. 4, B and D). Fig. 4 E presents the force
spectrum (i.e., force versus loading rate relation) of the a5b1/
FN7-10 interaction for loading rates of 20 pN/s to 50,000
pN/s. The force spectrum revealed that the rupture force of
the a5b1/FN7-10 complex increased gradually over three
orders of magnitude in loading rate. After a5b1 activation
with the TS2/16 antibody, the rupture forces of the complex
were elevated over the range of loading rates between 20 to
10,000 pN/s, but did not change the dynamic response of the
FIGURE 4 Measurements of the rupture force of individual a5b1 integrin/
fibronectin bonds at different loading rates. (A, B) Force histograms of a5b1/
FN7-10 interaction at (A) slow (230 pN/s) and (B) fast (13,000 pN/s)
loading rates. (C, D) Force histograms of the high affinity a5b1/FN7-10
interaction (activated by TS2/16) at (C) slow (240 pN/s) and (D) fast (13,500
pN/s) loading rates. The fitted probability density functions (Eq. 1) in A–D
were obtained using the Bell model parameters listed in Table 1. (E) Single
molecule force measurements between FN7-10 and unactivated K562 cells
(open circle) or 10% TS2/16 activated K562 cells (solid circle) as a function
of loading rates. The best-fit curves (gray lines) were obtained using Eq. 2
(see Discussion).
FIGURE 3 (A) Force-displacement traces
between K562 and FN7-10 under conditions
of minimal contact. Two of the six traces (first
and fifth) revealed adhesion. fr is the rupture
force of the a5b1 integrin/FN bond. ks is the
system spring constant and is used to determine
the loading rate of the measurement. The
cantilever retraction rate of the measurements
was 5 mm/s. (B) Mean rupture forces of in-
dividual a5b1 integrins complexed to FN7-10,
FN7-10 (DRGD), and FN7-10(Dsyn). Measure-
ments were acquired at a loading rate of 1,800
pN/s. Open and gray bars correspond to measurements from untreated and TS2/16 activated cells, respectively. The error bar is the standard error of the mean.
(C) Adhesion frequency of K562/FN binding under conditions of limited tip–substrate contact. Open and gray bars correspond to adhesion frequen-
cies before and after the addition of the function-blocking antibody, JBS5 (20 mg/ml), respectively.
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complex at loading rates greater than 10,000 pN/s. Similar
results were obtained in force measurements between K562
cells and plasma fibronectin immobilized on a solid surface
(Fig. 5).
In our AFM measurements, it was assumed that the
measured rupture force stemmed from the unbinding of the
a5b1/FN complex, although there are other linkages that can
break during the measurement. For example, it is conceiv-
able that a5b1 could be extracted from the cell membrane or
that FN could come unbound from the surface of the petri
dish. However, inasmuch as the interaction of a5b1 with
plasma FN and FN7-10 displayed similar force spectra (Fig.
5), it is unlikely that the measured rupture force stemmed
from the detachment of FN. An earlier study (Garcia et al.,
1998a), using fluid shear to detach cells, showed that when
the a5b1/FN bond was stabilized by covalent cross-linking,
the force for detachment doubled. This implies that this bond
is weaker than that holding the integrin in the membrane, or
attaching FN to the substrate. Nevertheless, to demonstrate
that a5b1 remained anchored to the cell membrane, we fixed
K562 cells by brief exposure to a 1% glutaraldehyde
solution. As shown in Fig. 6, the force spectrum of the
a5b1/FN complex obtained using the fixed cells is similar to
the force spectrum obtained using live cells, an observation
that is consistent with a5b1 remaining attached to the cell.
Considered together, these observations are all consistent
with the measured breakage occurring at the a5b1/FN
junction. Moreover, the measurements acquired with the
fixed cells also served to demonstrate that the viscoelastic
properties of the K562 cell did not significantly alter the
force measurements.
Deletion of the RGD loop from FN7-10
suppressed the rupture force at fast
loading rates
To assess the role of the RGD loop of FN10 in the
interactions of a5b1 with FN, we have also carried out AFM
measurements between individual a5b1 integrin and a fibro-
nectin fragment with the RGD loop deleted. Although the
interaction between a5b1 and FN7-10(DRGD) was weak, we
were able to demonstrate specific binding by measuring the
adhesion frequency before and after the addition of the
inhibitory anti-a5 monoclonal antibody JBS5. Under con-
ditions that resulted in an initial 10% adhesion frequency, the
addition of the JBS5 lowered the adhesion frequency to
\3%, a 70% reduction (Fig. 3C). The addition of polyclonal
murine IgG (50 mg/ml) did not affect adhesion (data not
shown).
Fig. 7 presents the force spectra of the interaction between
the FN7-10 RGD deletion mutant and a5b1 of untreated and
TS2/16 activated K562 cells. There were two striking
differences between FN7-10(DRGD) and wild type FN7-
10. First, the TS2/16 antibody showed no elevation of the
rupture force. The force at lower loading rates was
comparable to that for FN7-10, but there was no increase
upon activation. Second, the binding to FN7-10(DRGD) did
not show the increase in slope at high loading rates. Thus,
it appears that the inner activation barrier of the a5b1/FN
interaction was suppressed by the deletion of the RGD
sequence from FN.
FIGURE 6 Single molecule force measurements of the interactions
between live K562 (open circle) or fixed K562 cells (solid circle) and
FN7-10. The mode rupture force is plotted as a function of loading rates.
FIGURE 5 Single molecule force measurements between human plasma
fibronectin and unactivated K562 cells (open square) or K562 cells (solid
square) activated by TS2/16. The mode rupture force is plotted as a function
of loading rates. Measurements of the a5b1/FN7-10 interaction are plotted in
open and closed circles.
TABLE 1 Bell model parameters of the
a5b1/ﬁbronectin interaction
a5b1/FN pair Loading rate (pN/s) k8 (s1) g (A˚)
la5b1/FN7-10 20–10,000 0.13 4.1
10,000–50,000 33.5 0.86
ha5b1/FN7-10 20–10,000 0.012 4.4
10,000–50,000 29.1 0.91
la5b1/FN7-10(DRGD) 20–50,000 0.13 4.6
ha5b1/FN7-10(DRGD) 20–50,000 0.19 4.1
la5b1/FN7-10(Dsyn) 20–10,000 0.85 3.65
10,000–50,000 25.0 0.95
ha5b1/FN7-10(Dsyn) 20–10,000 0.66 3.27
10,000–50,000 24.9 0.91
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Mutations to the synergy site of ﬁbronectin
suppressed the rupture force at slow
loading rates
The binding of FN to a5b1 is significantly enhanced by
interactions of the synergy site residues within FN9 with
a5b1 (Aota et al., 1994; Kimizuka et al., 1991; Obara et al.,
1988; Redick et al., 2000; Kauf et al., 2001). To assess the
contribution of the synergy site residues in the a5b1/FN
interaction, we have carried out AFM force measurements
with a FN fragment with triple mutations in the synergy site
(R1374A/P1376A/R1379A) (Fig. 8). The interaction be-
tween a5b1 and FN7-10(Dsyn), the synergy site mutant, was
weak, but detectable. As with the RGD deletion mutant, the
binding to FN7-10(Dsyn) was not enhanced when the
integrin was activated by TS2/16. However, in contrast to the
RGD mutant, binding to FN7-10(Dsyn) showed the in-
creased force slope at high loading rates, essentially the same
as wild type FN7-10.
DISCUSSION AND CONCLUSIONS
A theoretical framework for understanding how force can
affect the adhesion complex was proposed by Bell (Bell et al.,
1984), and later expanded on by other researchers (Evans
and Ritchie, 1997; Merkel et al., 1999). In this model, an
applied force f distorts the energy landscape of the a5b1/FN
complex resulting in a lowering of the activation barrier(s),
and consequently increases the dissociation rate constant
k(f) as follows: k(f) ¼ k8 exp[fg/kBT] where k8 is the
dissociation rate constant in the absence of the applied
force, g is the position of the transition state, T is tem-
perature, and kB is Boltzmann’s constant. Under con-
ditions of constant loading rf, the probability density
function for the forced unbinding of the adhesion complex
is given by:
Pð f Þ ¼ k8 exp gf
kBT
 
exp
k8kBT
grf
1 exp gf
kBT
   
:
(1)
Moreover, the mode of the rupture force distribution fm can
be expressed as a linear function of the ln(rf),
fm ¼ kBT
g
ln
g
k8kBT
 
þ kBT
g
lnðrfÞ; (2)
where the y-intercept is
yo ¼ kBT
g
ln
g
k8kBT
 
and the slope
m ¼ kBT
g
:
(see Tees et al., 2001). The force-induced dissociation of
a ligand–receptor complex may involve overcoming multi-
ple activation energy barriers. In the case where the system
must overcome a series of increasingly higher activation
barriers before final dissociation, the dissociation kinetics of
the complex at low pulling forces is governed by the
properties of the outermost barrier. With increasing pulling
forces the outermost barriers are suppressed and the
dissociation kinetics of the system is then governed by the
properties of an inner activation barrier. Similarly, the force
spectrum of the system is divided into multiple loading
regimes that characterize the individual activation energy
barriers. The dynamic strength (i.e., rupture forces) of the
complex measured in slow loading regimes characterizes the
outermost activation energy barriers, whereas the force
measurements obtained in the fast loading regimes charac-
terize the innermost barriers (Evans and Ritchie, 1997).
An examination of the force spectra of the a5b1/FN7-10
interaction revealed that our measurements of the a5b1/FN7-
10 interaction are not compatible with the single barrier Bell
model. However the acquired force spectra is consistent with
FIGURE 8 Measurements of the rupture force between individual FN7-
10(Dsyn) and unactivated K562 (open square) or activated K562 (solid
square) cells. The mode rupture force is plotted as a function of loading
rates. The data plotted in gray circles are measurements between FN7-10 and
unactivated K562 (open circle) or activated K562 cells (solid circle).
FIGURE 7 Measurements of the rupture force between individual FN7-10
(DRGDS) and a5b1 integrin in unactivated K562 (open square) or activated
K562 cells (solid square). The mode rupture force is plotted as a function of
loading rates. The data plotted in gray circles are measurements between
FN7-10 and unactivated K562 (open circle) or activated K562 cells (solid
circle).
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an intermolecular potential that consisted of two activation
energy barriers. These energy barriers were characterized by
fitting Eq. 2 to the acquired force measurements. The fitted
curves are overlaid on the measurements in Fig. 4 E and the
best-fit parameters, k8 and g, are tabulated in Table 1. In
Table 1, la5b1 and ha5b1 correspond to the low and high
affinity form of a5b1, respectively. This analysis revealed
that the forced unbinding of a5b1/FN7-10 complex involved
overcoming at least two activation barriers. The positions of
the transition states of the inner and outer barriers from
equilibrium are ;0.9 A˚ and ;4.2 A˚, respectively, for both
the low and high affinity forms of the a5b1/FN7-10 complex.
Moreover, our analysis revealed that the observed increase in
rupture force after integrin activation in the low loading
regime stemmed from an elevation of the outer activation
energy barrier, which is manifested in a lowering of the
dissociation rate constant from 0.13/s to 0.012/s. These
values are consistent with the dissociation rates obtained in
other studies (Akiyama and Yamada, 1985; Thoumine et al.,
2000). The inner activation barrier appeared unaffected by
the integrin activation via TS2/16 inasmuch as there was no
change in the dynamic strength of the complex in the fast
loading regime after activation. To determine more precisely
the change in activation energy of the complex after TS2/16
binding, we estimated that the energy differences (DDGy)
between transition state energies of high and low affinity
complexes (DGyH) and (DG
y
L) to be ;0.14 kBT for the inner
barrier and;2.38 kBT for the outer barrier (see Fig. 9). From
this analysis, we concluded the high affinity state of the
a5b1/FN7-10 complex stemmed from the elevation of the
outer activation energy barrier of the complex.
Fig. 10 A presents the kinetic profiles of the a5b1/FN7-10
interaction. Here, the dissociation rate constant is expressed
as a function of pulling force, f, according to:
koff ¼ 1

k181 exp fg1=kBT½  þ k281 exp fg2=kBT½ 
 
;
where the subscripts 1 and 2 refer to inner and outer
activation energy barriers, respectively (Evans et al., 2001).
The kinetic profiles revealed the profound impact of a pulling
force on the rate of unbinding of the a5b1/FN7-10 complex
(Fig. 10 A). As shown, the dissociation rate constant
increased exponentially with pulling force from a zero force
off rate of ;0.012/s to ;3/s for activated a5b1 at a force of
50 pN. The off rate also increased by about the same amount
for low affinity a5b1. The kinetic profiles also revealed that
the dissociation rate was less responsive to change in force at
higher pulling forces ([;90 pN). It is this ability to resist
dissociation at high forces that allowed the a5b1/FN7-10
complex to mediate strong adhesion. It should be noted that
the dynamic responses of both low and high affinity forms of
the a5b1/FN7-10 interaction are nearly identical at high
forces, which would suggest that the molecular determinants
of the inner barrier are the same for both high and low
affinity a5b1/FN7-10 complexes.
FIGURE 9 Intermolecular potential of the a5b1/FN7-10 interaction. The
forced dissociation of the a5b1/FN7-10 involves overcoming two transition
states, TS1 and TS2. Estimates of the equilibrium free energies (DGO) were
derived from the equilibrium affinity constants reported in Takagi et al.
(2001). (l) and (h) denote energies corresponding to the low and high affinity
a5b1/FN7-10 complexes, respectively. Estimates of the energy difference
(DG12) between TS1 and TS2 were obtained using: DG12 ¼kBT ln(k81/k82)
where k81 and k82 are the dissociation rate constants of the inner and outer
activation energy barriers, respectively. Estimates of the energy difference
(DG01) between TS1 and the bound state were based on the inequality: DG12
þ DG01 $ DG8.
FIGURE 10 Kinetic profiles of the a5b1/FN interaction. (A) Effects of
FN7-10 mutations on the kinetic profile of the a5b1/FN interaction. (B)
Comparison of the kinetic profiles of the a5b1/FN7-10 interaction with the
LFA-1/ICAM-1 interaction.
Integrin–Fibronectin Interaction 1259
Biophysical Journal 84(2) 1252–1262
Clues into the molecular determinants of the inner and
outer activation barriers were derived from the force
measurements obtained with site-directed mutants of FN7-
10. The RGD loop in domain 10 of FN is crucial for integrin
binding. In the aVb3 integrin, the RGD sequence interacts
with both the a- and b-subunits (Xiong et al., 2002). The
crucial interaction is the electrostatic interaction between the
asparate residue of the RGD sequence and the chelated Mg2þ
ion in MIDAS of the bA domain of the b1 subunit. Our
studies revealed that the deletion of the RGD loop from FN7-
10 resulted in the suppression of rupture force of the a5b1/
FN complex in the fast loading regime ([10,000 pN/s; Fig.
7). This region of the force spectrum characterizes the inner
activation barrier of the complex. Thus, interactions
mediated by the RGD sequence appear to be responsible
for the inner activation barrier. However, it should be
emphasized that deleting the RGD also affected the low
force, outer barrier region, where it eliminated the enhanced
binding upon integrin activation. Moreover, the frequency of
adhesion was substantially reduced for the DRGD mutant.
Ligand binding is enhanced by the interactions mediated
by synergy site residues in FN9 and the b-propeller of a5.
Our force measurements suggest that the synergy site does
not contribute to the inner barrier, but does contribute to the
outer barrier of a5b1/FN complex. Just as with the RGD
deletion, FN7-10(Dsyn) showed weak binding to unactivated
integrin and no enhanced binding upon integrin activation.
A further interpretation is that integrin activation involves
the outer barrier, which is important in the low force region.
At forces of ;5 pN, the force generated by a single myosin
or kinesin, the outer barrier, and its regulation by integrin
activation is the biologically important feature in the dy-
namics of adhesion.
It is worthwhile to compare the dynamic response of the
a5b1/FN7-10 interaction to other direct force measurements
of ligand–receptor interactions. Litvinov et al. (2002) used
a laser tweezer apparatus to measure the rupture force of the
platelet integrin aIIbb3 complexed to its ligand fibrinogen.
The reported peak rupture force of 80–100 pN was slightly
less than the 120 pN peak that we measured for a5b1/FN at
the loading rate of 18,000 pN/s. Interestingly, the authors of
this study observed an increase in adhesion frequency upon
cell activation by the agonists ADP and thrombin receptor-
activating peptide that was attributed to the a change in the
accessibility of aIIbb3, but observed no change in the rupture
force of the integrin/fibrinogen complex upon cell activation.
These results are consistent with our findings that both high
and low affinity a5b1/FN7-10 complexes exhibited similar
rupture forces in the fast loading regime.
Multiple regimes of loading have also been detected in
other ligand–receptor systems. In the streptavidin-biotin
study, the different loading regimes correlated well with
major transitions in the energy landscape of simulated
ligand–receptor unbinding (Merkel et al., 1999). Complete
force spectra have been obtained for two other binding pairs
of adhesion molecules, L-selectin/sLex and LFA-1/ICAM-1,
both of which showed a transition to higher slope as loading
rates surpassed 10,000 pN/s (Evans et al., 2001; Zhang et al.,
2002). Thus, these systems also have inner and outer
barriers, which may be common characteristics of all cell
adhesion molecules. Moreover, it appears that the inner
barrier of these complexes stemmed from electrostatic in-
teraction between a chelated metal cation and a negatively
charged amino acid in the binding partner. The adhesion
molecule L-selectin binding to its carbohydrate ligand gave
a force spectrum with a shape similar to that of a5b1/FN, but
with significantly lower forces (Evans et al., 2001). The most
frequent rupture forces were 20 and 70 pN at 200 and 20,000
pN/s. In contrast, the adhesion of LFA-1, a leukocyte
integrin, binds to its ligand ICAM-1 with higher forces than
that of a5b1/FN (Zhang et al., 2002).
A comparison of kinetic profiles of the a5b1/FN7-10 and
LFA-1/ICAM-1 complexes revealed that although the a5b1/
FN7-10 interaction is more stable than the LFA-1/ICAM-1
interaction with slow dissociation kinetics in the absence of
force, the force dependent dissociation of a5b1/FN7-10
interaction is more sensitive to a pulling force. The dis-
sociation rate of the a5b1/FN7-10 complex quickly exceeds
the dissociation of the LFA-1/ICAM-1 complex at ;50 pN
(Fig. 10 B). This analysis shows that the LFA-1/ICAM-1
complex is a more stable adhesion system at force[50 pN
and suggests that the a5b1/FN7-10 interaction may not be
suited for resisting a large pulling force.
In summary, the current study has identified two barriers
to the unbinding of the a5b1/FN complex. An inner barrier,
which is affected by deletion of RGD, but not by the synergy
site, is seen at high forces that may not be physiologically
important. An outer barrier operates at lower, physiologi-
cally relevant forces. This outer barrier is affected by both
RGD and synergy regions, and it is the site of integrin
activation. FN lacking either RGD or synergy site binds
weakly to a5b1, and there is no enhancement of binding
upon integrin activation. In this low force region a5b1
binding to FN is substantially stronger, with an ;10-fold
longer lifetime, than the binding of LFA to ICAM-1.
We thank A. Chen for insightful discussions, C. Freites for technical
support, and the reviewers for constructive comments of the original
manuscript.
This work was supported by grants from the American Cancer Society and
the National Institutes of Health (1 R29 GM55611-01 and R01 CA47056).
REFERENCES
Akiyama, S. K., and S. S. Yamada. 1985. The interaction of plasma
fibronectin with fibroblastic cells in suspension. J. Biol. Chem.
260:4492–4500.
Aota, S., M. Nomizu, and K. M. Yamada. 1994. The short amino acid
sequence Pro-His-Ser-Arg-Asn in human fibronectin enhances cell-
adhesive function. J. Biol. Chem. 269:24756–24761.
1260 Li et al.
Biophysical Journal 84(2) 1252–1262
Arroyo,A.G.,A.Garcia-Pardo, andF. Sanchez-Madrid. 1993.Ahigh affinity
conformational state onVLA integrin heterodimers induced by an anti-beta
1 chain monoclonal antibody. J. Biol. Chem. 268:9863–9868.
Aukhil, I., P. Joshi, Y. Yan, and H. P. Erickson. 1993. Cell- and heparin-
binding domains of the hexabrachion arm identified by tenascin
expression proteins. J. Biol. Chem. 268:2542–2553.
Barillari, G., L. Albonici, S. Incerpi, L. Bogetto, G. Pistritto, A. Volpi,
B.Ensoli, andV.Manzari.2001. Inflammatorycytokines stimulatevascular
smooth muscle cells locomotion and growth by enhancing alpha5beta1
integrin expression and function. Atherosclerosis. 154:377–385.
Bell, G. I., M. Dembo, and P. Bongrand. 1984. Cell adhesion. Competition
between nonspecific repulsion and specific bonding. Biophys. J. 45:
1051–1064.
Benoit, M., D. Gabriel, G. Gerisch, and H. E. Gaub. 2000. Discrete
interactions in cell adhesion measured by single-molecule force
spectroscopy. Nat. Cell Biol. 2:313–317.
Bowditch, R. D., M. Hariharan, E. F. Tominna, J. W. Smith, K. M.
Yamada, E. D. Getzoff, and M. H. Ginsberg. 1994. Identification of
a novel integrin binding site in fibronectin. Differential utilization by beta
3 integrins. J. Biol. Chem. 269:10856–10863.
Burrows, L., K. Clark, A. P. Mould, and M. J. Humphries. 1999. Fine
mapping of inhibitory anti-a5 monoclonal antibody epitopes that
differentially affect integrin–ligand binding. Biochem. J. 344:527–533.
Caixia, S., S. Stewart, E.Wayner,W.Carter, and J.Wilkins. 1991.Antibodies
to different members of the b-1 (CD29) integrins induces homotypic and
heterotypic cellular aggregation. Cell. Immunol. 138:216–228.
Chen, S., and T. A. Springer. 2001. Selectin receptor-ligand bonds:
Formation limited by shear rate and dissociation governed by the Bell
model. Proc. Natl. Acad. Sci. USA. 98:950–955.
Coe, A. P., J. A. Askari, A. D. Kline, M. K. Robinson, H. Kirby, P. E.
Stephens, and M. J. Humphries. 2001. Generation of a minimal a5 b1
integrin-Fc fragment. J. Biol. Chem. 276:35854–35866.
Danen, E. H., S. Aota, A. A. van Kraats, K. M. Yamada, D. J. Ruiter, and
G. N. van Muijen. 1995. Requirement for the synergy site for cell
adhesion to fibronectin depends on the activation state of integrin a5 b1.
J. Biol. Chem. 270:21612–21618.
Evans, E., and K. Ritchie. 1997. Dynamic strength of molecular adhesion
bonds. Biophys. J. 72:1541–1555.
Evans, E., K. Ritchie, and R. Merkel. 1995. Sensitive technique to probe
molecular adhesion and structural linkages at biological interfaces.
Biophys. J. 68:2580–2587.
Evans, E., A. Leung, D. Hammer, and S. Simon. 2001. Chemically distinct
transition states govern rapid dissociation of single L-selectin bonds
under force. Proc. Natl. Acad. Sci. USA. 98:3784–3789.
Fernandez, C., K. Clark, L. Burrows, N. R. Schofield, and M. J. Humphries.
1998. Regulation of the extracellular ligand binding activity of integrins.
Front. Biosci. 3:684–700.
Fritz, J., A. G. Katopodis, F. Kolbinger, and D. Anselmetti. 1998. Force-
mediated kinetics of single P-selectin/ligand complexes observed by
atomic force microscopy. Proc. Natl. Acad. Sci. USA. 95:12283–12288.
Garcia, A. J., F. Huber, and D. Boettiger. 1998a. Force required to break
a5b1 integrin–fibronectin bonds in intact adherent cells is sensitive to
integrin activation state. J. Biol. Chem. 273:10988–10993.
Garcia, A. J., J. Takagi, and D. Boettiger. 1998b. Two-stage activation for
a5b1 integrin binding to surface-adsorbed fibronectin. J. Biol. Chem.
273:34710–34715.
Garcia, A. J., M. D. Vega, and D. Boettiger. 1999. Modulation of cell
proliferation and differentiation through substrate-dependent changes in
fibronectin conformation. Mol. Biol. Cell. 10:785–798.
George, E. L., E. N. Georges-Labouesse, R. S. Patel-King, H. Rayburn, and
R. O. Hynes. 1993. Defects in mesoderm, neural tube and vascular
development in mouse embryos lacking fibronectin. Development.
119:1079–1091.
Goh, K. L., J. T. Yang, and R. O. Hynes. 1997. Mesodermal defects and
cranial neural crest apoptosis in a5 integrin-null embryos. Development.
124:4309–4319.
Greiling, D., and R. A. Clark. 1997. Fibronectin provides a conduit for
fibroblast transmigration from collagenous stroma into fibrin clot
provisional matrix. J. Cell Sci. 110:861–870.
Heinz, W. F., and J. H. Hoh. 1999. Spatially resolved force spectroscopy of
biological surfaces using the atomic force microscope. Trends
Biotechnol. 7:143–150.
Hemler, M. E., C. Huang, and L. Schwarz. 1987. The VLA protein family.
Characterization of five distinct cell surface heterodimers each with
a common 130,000 molecular weight b-subunit. J. Biol. Chem.
262:3300–3309.
Hocking, D. C., J. Sottile, and P. J. McKeown-Longo. 1998. Activation of
distinct a5b1-mediated signaling pathways by fibronectin’s cell adhesion
and matrix assembly domains. J. Cell Biol. 141:241–253.
Hutter, J. L., and J. Bechhoefer. 1993. Calibration of atomic-force
microscope tips. Rev. Sci. Instrum. 64:1868–1873.
Hynes, R. O. 1992. Integrins: versatility, modulation, and signaling in cell
adhesion. Cell. 69:11–25.
Kauf, A. C., S. M. Hough, and R. D. Bowditch. 2001. Recognition
of fibronectin by the platelet integrin aIIb b3 involves an extended
interface with multiple electrostatic interactions. Biochemistry. 40:9159–
9166.
Kimizuka, F., Y. Ohdate, Y. Kawase, T. Shimojo, Y. Taguchi, K. Hashino,
S. Goto, H. Hashi, I. Kato, K. Sekiguchi, and K. Titani. 1991. Role of
type III homology repeats in cell adhesive function within the cell-
binding domain of fibronectin. J. Biol. Chem. 266:3045–3051.
Litvinov, R. I., H. Shuman, J. S. Bennett, and J. W. Weisel. 2002. Binding
strength and activation state of single fibrinogen-integrin pairs on living
cells. Proc. Natl. Acad. Sci. USA. 99:7426–7431.
Leahy, D. J., I. Aukhil, and H. P. Erickson. 1996. 2.0. A crystal structure of
a four-domain segment of human fibronectin encompassing the RGD
loop and synergy region. Cell. 84:155–164.
Lehenkari, P. P., and M. A. Horton. 1999. Single integrin molecule
adhesion forces in intact cells measured by atomic force microscopy.
Biochem. Biophys. Res. Commun. 259:645–650.
Merkel, R., P. Nassoy, A. Leung, K. Ritchie, and E. Evans. 1999. Energy
landscapes of receptor–ligand bonds explored with dynamic force
spectroscopy. Nature. 397:50–53.
Molla, A., and M. R. Block. 2000. Adherence of human erythroleukemia
cells inhibits proliferation without inducing differentiation. Cell Growth
Differ. 11:83–90.
Mould, A. P., S. K. Akiyama, and M. J. Humphries. 1995. Regulation of
integrin a5 b1-fibronectin interactions by divalent cations. Evidence for
distinct classes of binding sites for Mn2þ, Mg2þ, and Ca2þ. J. Biol.
Chem. 270:26270–26277.
Mould, A. P., J. A. Askari, S. Aota, K. M. Yamada, A. Irie, Y. Takada,
H. J. Mardon, and M. J. Humphries. 1997. Defining the topology of
integrin a5b1-fibronectin interactions using inhibitory anti-a5 and anti-
b1 monoclonal antibodies. Evidence that the synergy sequence of
fibronectin is recognized by the amino-terminal repeats of the a5 subunit.
J. Biol. Chem. 272:17283–17292.
Mould, A. P., L. Burrows, and M. J. Humphries. 1998. Identification of
amino acid residues that form part of the ligand-binding pocket of
integrin a5 b1. J. Biol. Chem. 273:25664–25672.
Mould, A. P., J. A. Askari, and M. J. Humphries. 2000. Molecular basis of
ligand recognition by integrin a5 b1. I. Specificity of ligand binding is
determined by amino acid sequences in the second and third NH2-
terminal repeats of the a-subunit. J. Biol. Chem. 275:20324–20336.
Moy, V. T., E.-L. Florin, and H. E. Gaub. 1994. Adhesive forces bet-
ween ligand and receptor measured by AFM. Colloids Surfaces. 93:
343–348.
Obara, M., M. S. Kang, and K. M. Yamada. 1988. Site-directed
mutagenesis of the cell-binding domain of human fibronectin: separable,
synergistic sites mediate adhesive function. Cell. 53:649–657.
Oberhauser, A. F., P. E. Marszalek, H. P. Erickson, and J. M. Fernandez.
1998. The molecular elasticity of the extracellular matrix protein ten-
ascin. Nature. 393:181–185.
Integrin–Fibronectin Interaction 1261
Biophysical Journal 84(2) 1252–1262
Pierini, L. M., M. A. Lawson, R. J. Eddy, B. Hendey, and F. R. Maxfield.
2000. Oriented endocytic recycling of a5 b1 in motile neutrophils.
Blood. 95:2471–2480.
Pierschbacher, M. D., and E. Ruoslahti. 1984. Cell attachment activity of
fibronectin can be duplicated by small synthetic fragments of the
molecule. Nature. 309:30–33.
Redick, S. D., D. L. Settles, G. Briscoe, and H. P. Erickson. 2000. Defining
fibronectin’s cell adhesion synergy site by site-directed mutagenesis.
J. Cell Biol. 149:521–527.
Springer, T. A. 1997. Folding of the N-terminal, ligand-binding region of
integrin a-subunits into a b-propeller domain. Proc. Natl. Acad. Sci.
USA. 94:65–72.
Takagi, J., H. P. Erickson, and T. A. Springer. 2001. C-terminal opening
mimics inside-out activation of integrin a5b1. Nat. Struct. Biol.
8:412–416.
Taverna, D., and R. O. Hynes. 2001. Reduced blood vessel formation and
tumor growth in a5-integrin-negative teratocarcinomas and embryoid
bodies. Cancer Res. 61:5255–5261.
Tees, D. F., R. E. Waugh, and D. A. Hammer. 2001. A microcantilever
device to assess the effect of force on the lifetime of selectin–
carbohydrate bonds. Biophys. J. 80:668–682.
Thoumine, O., P. Kocian, A. Kottelat, and J. J. Meister. 2000. Short-term
binding of fibroblasts to fibronectin: optical tweezers experiments and
probabilistic analysis. Eur. Biophys. J. 29:398–408.
Thoumine, O., and J. J. Meister. 2000. Dynamics of adhesive rupture
between fibroblasts and fibronectin: microplate manipulations and
deterministic model. Eur. Biophys. J. 29:409–419.
Tsuchida, J., S. Ueki, Y. Takada, Y. Saito, and J. Takagi. 1998. The
‘‘ligand-induced conformational change’’ of a5 b1 integrin. Relocation
of a5 subunit to uncover the b1 stalk region. J. Cell Sci. 111:1759–
1766.
Wayner, E. A., S. G. Gil, G. F. Murphy, M. S. Wilke, and W. G. Carter.
1993. Epiligrin, a component of epithelial basement membranes, is an
adhesive ligand for a3 b1 positive T lymphocytes. J. Cell Biol.
121:1141–1152.
Xiong, J. P., T. Stehle, B. Diefenbach, R. Zhang, R. Dunker, D. L. Scott,
A. Joachimiak, S. L. Goodman, and M. A. Arnaout. 2001. Crystal
structure of the extracellular segment of integrin aVb3. Science.
294:339–345.
Xiong, J. P., T. Stehle, R. Zhang, A. Joachimiak, M. Frech, S. L. Goodman,
and M. A. Arnaout. 2002. Crystal structure of the extracellular segment of
integrin aVb3 in complex with an arg-gly-asp ligand. Science. 296:151–155.
Yamada, K. M., and D. W. Kennedy. 1984. Dualistic nature of adhesive
protein function: fibronectin and its biologically active peptide fragments
can autoinhibit fibronectin function. J. Cell Biol. 99:29–36.
Yamada, K. M., and S. Miyamoto. 1995. Integrin transmembrane signaling
and cytoskeletal control. Curr. Opin. Cell Biol. 7:681–689.
Zhang, X., E. Wojcikiewicz, and V. T. Moy. 2002. Force spectroscopy
of the leukocyte function-associated antigen-1 (LFA-1)/inter-
cellular adhesion molecule-1 (ICAM-1) interaction. Biophys. J.
83:2270–2279.
1262 Li et al.
Biophysical Journal 84(2) 1252–1262
